Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Preferred Stock Liabilities: 2019-2020

  • Biodesix's Preferred Stock Liabilities was N/A to $194.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $194.0 million, marking a year-over-year change of. This contributed to the annual value of $194.0 million for FY2019, which is N/A change from last year.
  • According to the latest figures from Q3 2020, Biodesix's Preferred Stock Liabilities is $194.0 million, which was down 0.00% from $194.0 million recorded in Q4 2019.
  • Biodesix's Preferred Stock Liabilities' 5-year high stood at $194.0 million during Q4 2019, with a 5-year trough of $194.0 million in Q4 2019.
  • Over the past 2 years, Biodesix's median Preferred Stock Liabilities value was $194.0 million (recorded in 2020), while the average stood at $194.0 million.